Clinical trials
Clinical clinical trials
Below are recruiting clinical clinical trials, each written for real people, not researchers. We’re tracking 5,435 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06840002RecruitingPhase 1/Phase 2
Targeted drug plus chemotherapy for recurrent ovarian cancer
This trial tests a new targeted drug, SHR-A1811, combined with chemotherapy for women whose ovarian cancer has returned but still responds to platinum-based drugs. The goal is to see if the combination works better than chemotherapy alone.
Wuhan, HubeiAges 18–75 - NCT06839833Recruiting
APOL1 gene test study for trial volunteers
This study checks if a new genetic test for the APOL1 gene works correctly. It uses samples from people who have already joined another drug trial.
Durham, North CarolinaAges 18–70 - NCT06307080Recruiting
Combined ablation and immunotherapy for pancreatic cancer with liver spread
This study tests a new treatment combining tumor destruction with heat/cold (ablation) and an immunotherapy drug (PD-1) for people whose pancreatic cancer has spread to the liver. The goal is to help the immune system fight the cancer better.
Shanghai, Shanghai MunicipalityAges 18–70 - NCT06805097Recruiting
Platelet transfusion for low platelet counts in blood cancer patients
This trial tests how well platelet transfusions work for patients with blood cancers or bone marrow failure who have very low platelets and need a transfusion. It aims to see if the transfusions help control bleeding and improve outcomes.
BesançonAges 18 years+ - NCT06837857RecruitingPhase 2
Opioid pain relief study for older adults with chronic pain
This study tests whether a carefully managed prescription opioid can safely help older adults with long-term pain that hasn't been relieved by other pain medicines. The goal is to see if it improves pain without harming memory or brain health.
Rochester, MinnesotaAges 65 years+ - NCT06839274Recruiting
Follicle size and egg maturity in poor responders
This trial looks at how the size of ovarian follicles (fluid sacs that contain eggs) affects egg maturity in women who have a low egg count. It may help improve egg freezing or IVF success.
Abu Dhabi, Abu Dhabi EmirateAges 18–48 - NCT06846138Enrolling by invitation
Herbal supplement to help metformin work better and cause fewer side effects
This study tests a special herbal blend added to metformin to see if it helps reduce stomach problems and improves blood sugar control in people with type 2 diabetes. Researchers want to understand how the herbs affect the bacteria in your gut.
RigaAges 25–80 - NCT06843629Recruiting
PET scan test for MSLN in cancer patients
This study uses a special PET scan to look for a protein called MSLN in certain cancers like pancreatic, ovarian, and lung cancer. It aims to see if this imaging method can help doctors understand your tumor better.
Wuhan, HubeiAges 18–65 - NCT06843499Recruiting
AI eye screening for AMD and diabetic retinopathy
This trial tests an AI program called VeriSee that helps doctors check for eye problems like age-related macular degeneration (AMD) and diabetic retinopathy (DR). It compares the AI's accuracy and costs to standard care in regular eye clinics.
Taipei, TaiwanAges 20 years+ - NCT06839105RecruitingPhase 1
Testing AWT020 for advanced cancers
This study tests an experimental drug called AWT020 in people with advanced cancers that have either stopped responding to standard treatments or aren't candidates for them. The goal is to see if AWT020 is safe and tolerable across several cancer types such as lung cancer, melanoma, colorectal cancer, kidney cancer, and others.
Fuzhou, FujianAges 18 years+ - NCT06837064Enrolling by invitation
Can a chatbot help manage Irritable Bowel Syndrome?
This study tests whether a chatbot can help adults with Irritable Bowel Syndrome (IBS) manage their symptoms. If you have been diagnosed with IBS, you may be able to join and use the chatbot as part of your care.
MoscowAges 18 years+ - NCT06845527Recruiting
Gut bacteria testing in a clinic study
This study looks at people who visit a special gut bacteria clinic. It aims to learn more about their health by testing their gut bacteria as part of regular care.
Rome, RMAges 18 years+ - NCT06843005Recruiting
Heart CT scan study for plaque changes in mild coronary disease
This study uses repeat CT scans of the heart to see how plaque buildup changes over time in people with mild, non-blocking coronary artery disease. It may help doctors decide on better treatments to prevent future heart problems.
Nanjing, JiangsuAges 18–80 - NCT06845345Enrolling by invitationPhase 4
Can a special diet or pills help liver health?
This study compares two treatments for liver scarring in people with overweight or related health issues. One group follows a special diet with restricted eating times, while the other takes a combination of two medications (naltrexone and bupropion). It aims to see which approach better improves liver fibrosis.
RotterdamAges 18–75 - NCT06844383RecruitingPhase 2
Talazoparib with or without enzalutamide for prostate cancer after prior treatment
This study tests a drug called talazoparib, either alone or combined with enzalutamide, in people with prostate cancer that has spread and has a specific genetic change. The goal is to see if this treatment can help control the cancer after previous therapies have stopped working.
Duarte, CaliforniaAges 18 years+ - NCT06836089Enrolling by invitation
MRI study for dense breasts with a special imaging technique
This trial tests whether a type of MRI called Diffusion Weighted Imaging (DWI) can more accurately identify breast issues in women with dense breast tissue. If you have dense breasts and have already had a breast MRI with DWI, this study may help improve future diagnosis.
NaplesAges 40 years+ - NCT06843902RecruitingPhase 2
Improving heart blood flow in women with HIV and diabetes or kidney problems
This trial tests a new approach to improve blood flow in the hearts of women with HIV who also have diabetes or kidney problems. It might help prevent heart disease in this population.
Boston, MassachusettsAges 45–75 - NCT06846359Recruiting
Hypnotherapy for Upper Gut Symptoms
This study tests whether hypnotherapy sessions, delivered through a smartphone app, can help relieve upper digestive symptoms like nausea, bloating, and indigestion. It's for people whose symptoms are not caused by a known disease and who have already had normal stomach-emptying tests.
Rochester, MinnesotaAges 18 years+ - NCT06843109Enrolling by invitation
Memory clinic study on biomarkers for mild cognitive impairment
This study looks at brain changes in people with mild memory problems to find early signs of Alzheimer's disease. You and a study partner can help by sharing information about your daily life.
London, OntarioAges 55–80 - NCT06837038Enrolling by invitation
Rhythmic beats to improve walking after stroke or Parkinson's
This trial tests whether listening to rhythmic music while walking can improve gait problems caused by stroke, Parkinson's disease, or other parkinsonism conditions. It is designed for people who can walk on their own but have an uneven or slow pace.
Beijing, Beijing MunicipalityAges 50–80 - NCT06829784RecruitingPhase 3
Study of TQC2731 for severe asthma
This trial tests an investigational drug called TQC2731 for people with severe asthma that is not well controlled despite high-dose inhaled steroids. The study aims to see if this treatment can reduce asthma attacks.
Bozhou, AnhuiAges 18–75 - NCT06830031RecruitingPhase 1
C402-CD19-CAR treatment for relapsed or refractory B-cell lymphoma
This trial tests a new CAR-T cell therapy called C402-CD19-CAR for people with certain types of B-cell lymphoma that have come back or not responded to previous treatments. The treatment uses your own immune cells to target and kill cancer cells that have a protein called CD19 on their surface.
TianjinAges 18–75 - NCT06826196RecruitingPhase 1/Phase 2
Testing a new shot for patchy hair loss (alopecia areata)
This study tests a new medicine called ALD-102, given as a small shot in the scalp, to see if it helps hair grow back in people with alopecia areata. It is an early-stage trial looking at safety, how the body handles the drug, and whether it works.
Thousand Oaks, CaliforniaAges 18–55 - NCT06829771RecruitingPhase 1/Phase 2
A new drug combined with standard chemo for large B-cell lymphoma
This trial is testing a new drug called TQB2825 given alongside standard chemotherapy (R-CHOP or GemOx) for people with diffuse large B-cell lymphoma (DLBCL) or a related type called grade 3b follicular lymphoma. The goal is to see if adding this new drug is safe and works better than standard treatment alone.
Bengbu, AnhuiAges 18–80
Hear when a new Clinical trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for clinical?
- Yes. Clin2 currently lists 5,435 recruiting clinical studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a clinical trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a clinical trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.